Hans Preusting

Hans Preusting

Chief Operating Officer at MENDUS AB
64 year
Health Technology
Consumer Services
Commercial Services

Profile

Dr. Hans Preusting is a Chief Operating Officer at Mendus AB and a Chief Executive Officer at Synerkine Pharma BV.
He is on the Board of Directors at DCPrime BV, Oxyrane UK Ltd. and PharmaCell BV.
Dr. Preusting was previously employed as a Director-Operations & Business Development by Amsterdam Molecular Therapeutics (AMT) Holding NV, a Director-Influenza & Cell Culture Vaccine by Solvay Pharmaceuticals BV, a Manager-Operations by DSM Biologics Holding, Inc., a Chief Development Officer by DegenRx BV, and a Chief Business Officer by uniQure NV.
He received his MBA from Rotterdam School of Management, a doctorate degree from the University of Groningen and a doctorate degree from Rotterdam School of Management.

Hans Preusting active positions

CompaniesPositionStart
MENDUS AB Chief Operating Officer 05/10/2026
Chief Executive Officer -
Director/Board Member -
Director/Board Member -
Director/Board Member 01/04/2019

Former positions of Hans Preusting

CompaniesPositionEnd
Chief Operating Officer 11/03/2013
Corporate Officer/Principal 01/01/2006
Chief Operating Officer 01/01/2003
Corporate Officer/Principal -
░░░░░░░ ░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
See the detail of Hans Preusting's experience

Education of Hans Preusting

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

54

1st degree connections

12

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies12

Health Technology

Health Technology

Consumer Services

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Commercial Services

  1. Stock Market
  2. Insiders
  3. Hans Preusting